Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise
- 30 April 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 127 (2) , 368-381
- https://doi.org/10.1016/0008-8749(90)90139-i
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Isolation and characterization of trophoblast from murine placentaPlacenta, 1986
- Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasisCellular Immunology, 1986
- Changes in the host natural killer cell population in mice during tumor developmentCellular Immunology, 1985
- Immunoregulation of host-versus-graft responses in the uterusImmunology Today, 1984
- An evaluation of the maternal natural killer cell population during the course of murine pregnancyCellular Immunology, 1984
- Effect of Indomethacin on Reproduction Under Laboratory and Field Conditions in Deermice (Peromyscus maniculatus)Biology of Reproduction, 1983
- Induction of Decidualization in Rats by the Intrauterine Infusion of Prostaglandins1Biology of Reproduction, 1982
- Localization of H-2 antigens on mouse trophoblast cells.The Journal of Experimental Medicine, 1979
- Antifertility Effects of Indomethacin During Early Pregnancy in the RabbitBiology of Reproduction, 1978
- Evidence for a Role for Prostaglandins in the Initiation of Blastocyst Implantation in the Rat1Biology of Reproduction, 1977